REDWOOD CITY, Calif., Aug. 12, 2022 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR), a biotechnology company focused on developing multiple new therapies for the field of stem and cellular medicine, today announced second quarter 2022 financial results and provided a corporate update.
View original post here:
Jasper Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update
Recommendation and review posted by Fredricko
